Skip to main content

Table 3 Associations between serum IL-17 and CAP severity scores in CAP patients

From: Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study

Variables Univariable, OR (95% CI) P Multivariablea, OR (95% CI) P
SMART-COP
0–1 1 1
3–4 9.16 (3.16, 26.57)  < 0.01 8.93 (3.00, 26.55)  < 0.01
5–6 4.39 (1.90, 10.12)  < 0.01 3.63 (1.53, 8.62)  < 0.01
7–8 23.50 (6.07, 90.95)  < 0.01 18.12 (4.50, 72.99)  < 0.01
APACHE II
 < 4 1 1
4–6 0.95 (0.36, 2.47) 0.91 0.84 (0.30, 2.37) 0.74
6–10 1.47 (0.60, 3.60) 0.40 1.26 (0.47, 3.39) 0.64
 > 10 5.30 (2.32, 12.09)  < 0.01 4.03 (1.57, 10.30)  < 0.01
CRB-65
0 1 1
1–2 1.74 (0.84, 3.58) 0.14 1.29 (0.57, 2.91) 0.55
 ≥ 3 4.79 (1.83, 12.51)  < 0.01 3.32 (1.18, 9.35) 0.02
CURB-65
0–1 1 1
2 3.37(1.58, 7.21)  < 0.01 2.80 (1.27, 6.18) 0.01
3 ~ 5 5.38 (2.47, 11.75)  < 0.01 4.11 (1.78, 9.53)  < 0.01
PSI
I 1 1
II 1.75 (0.60, 5.15) 0.31 1.50 (0.46, 4.90) 0.50
III 1.75 (0.58, 5.23) 0.32 1.36 (0.38, 3.93) 0.64
IV 3.11 (1.08, 8.96) 0.04 2.40 (0.67, 8.67) 0.18
V 22.00 (5.86, 82.65)  < 0.01 15.41 (3.34, 70.03)  < 0.01
CURXO
Mild 1 1
Severe 5.98 (3.10, 11.53)  < 0.01 5.01 (2.55, 9.86)  < 0.01
  1. aAdjusted for age and sex